相关实验视频

Updated: Jun 26, 2025

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

使用AD-Mapper对阿尔茨海默病数据集的语义协调

Philipp Wegner^1,2,3, Helena Balabin^4,5, Mehmet Can Ay^1,6

¹Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany.

Journal of Alzheimer's disease : JAD

|May 17, 2024

概括

我们开发了AD-Mapper,这是一个用于协调阿尔茨海默病 (AD) 队列研究的自动工具. 这种工具显著提高了数据的一致性,以便更好地进行交叉队列分析.

科学领域:

生物医学信息学生物医学信息学
计算生物学计算生物学
神经科学数据科学数据科学

背景情况:

阿尔茨海默病 (AD) 队列研究的语义协调仍然是一个挑战.
现有的方法缺乏用于跨队列数据集成的自动化解决方案.
在AD研究中的数据驱动分析严重依赖于协调的队列数据.

研究的目的:

加速AD队列研究的语义协调.
开发一个自动化工具来改进跨队列分析.
为了提高数据的一致性和可比性跨不同的AD数据集.

主要方法:

通过交叉映射来自20个队列,三个CDM和本体学术语的数据,创建了一个共同的数据模型 (CDM).
使用开发的CDM微调了一个BioBERT模型.
评估了模型在三个未见的队列中的表现,与串匹配基线对比.

主要成果:

推出了AD-Mapper,这是一个用于自动协调AD队列研究的接口.
与未见的队列上的字符串匹配基线相比,AD-Mapper表现出卓越的性能.
展示了一个包含1218个唯一变量的全面CDM.

结论:

在命名惯例中,AD-Mapper有效地利用语义上的相似性,以提高协调性.
该工具为长期存在的AD队列数据协调挑战提供了一个强大的解决方案.
促进在阿尔茨海默病中更可靠,更有效的数据驱动的研究.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.自动数据协调与统一.队列研究是一项队列研究.一个共同的数据模型.数据互操作性数据的互操作性.语义映射是一个语义映射.

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...